A randomised, double-blind, placebo-controlled crossover trial of the influence of the HCN channel blocker ivabradine in a healthy volunteer pain model: an enriched population trial (2019)

First Author: Lee M

Attributed to: HCN ion channels and pain funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1097/j.pain.0000000000001638

PubMed Identifier: 31188268

Publication URI: http://europepmc.org/abstract/MED/31188268

Type: Journal Article/Review

Parent Publication: Pain

Issue: 11

ISSN: 0304-3959